医用大麻市场战略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00022901
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 181
Buy Now

 

[研究报告] 2021 年医用大麻市场规模价值 117.065 亿美元,预计到 2028 年将达到 400.2759 亿美元;预计 2022 年至 2028 年的复合年增长率为 19.2%。

 

分析师观点

医用大麻的种植和使用在美国已合法化。在美国,截至 2022 年 2 月,大麻已在 37 个州和哥伦比亚特区合法用于医疗用途。加拿大于 2018 年通过了《大麻法案》,该法案制定了严格的法规来控制全国范围内大麻的生产、分销、销售和持有。墨西哥、卢森堡、莱索托和其他几个国家最近将大麻的医疗用途合法化。乌拉圭是 2012 年第一个将大麻娱乐用途合法化的国家。另一方面,巴西于 2014 年批准医用大麻,并于 2016 年允许进口 CBD 油类药物、THC 类产品和大麻花。2017 年,秘鲁根据该立法批准了大麻及其衍生物的药用和治疗用途。

尽管许多国家已经将大麻的使用合法化,但大麻的种植和生产主要限于发展中国家。 2019 年 9 月,牙买加商业、农业和渔业部宣布与哈佛国际植物药和医用大麻研究所 (HIPI) 合作,对大麻的药理作用进行研究。牙买加还打算利用这一伙伴关系推动其国家大麻产业的发展。此外,世界卫生组织 (WHO) 报告称,全球约 80% 的人口将大麻或大麻用于医疗目的。因此,发展中国家对医用大麻的接受度、种植和生产日益增多,对医用大麻市场的增长做出了重大贡献

 

市场概况

医用大麻利用大麻植物或其成分来治疗疾病或病痛。它与娱乐用大麻是同一种产品,但用于医疗目的。医用大麻继续对医疗保健行业产生重大影响,特别是在传统药物并不完全适用的情况下。本质上,医用大麻只是一种典型的大麻植物,经过加工后获得合成产品所需的大麻素基本成分。促成这一市场增长的关键因素之一是医用大麻产品获得越来越多的批准,大麻的药用特性也越来越被人们接受。然而,大麻作为街头毒品的非法使用以及对大麻的误解也阻碍了市场的增长,这限制了大麻在医疗领域的潜在应用。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医用大麻市场:

医用大麻市场
  • Medical Marijuana Market
    复合年增长率(2021 - 2028 年)
    19.2%
  • 2021 年市场规模
    117.1 亿美元
  • 2028 年市场规模
    400.3 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • Aphria 公司
  • Canopy Growth 公司
  • 加拿奎斯特医疗公司
  • GW 制药公司
  • Organigram 控股公司
  • VIVO 大麻公司
  • 帕纳西亚制药工业有限公司
  • 凤凰控股有限公司
  • Emerald Health Therapeutics Inc.

区域概况

Medical Marijuana Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Medical Marijuana Market产品
  • 干燥形式和提取物形式
Medical Marijuana Market应用
  • 疼痛管理
  • 妥瑞氏症
  • 阿尔茨海默氏病
  • 偏头痛
  • 抑郁和焦虑
  • 多发性硬化症
  • 癌症
  • 其他的
Medical Marijuana Market分销渠道
  • 零售药店
  • 电子商务
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

市场驱动因素

医用大麻产品审批增多,推动医用大麻市场增长

大麻的药用潜力吸引了众多研究人员和公司将大麻用于医疗用途。例如,四氢大麻酚 (THC) 主要用于生产药品。美国食品药品管理局 (FDA) 已批准基于 THC 的药品,例如 Cesamet,其活性成分为纳博林,是一种合成衍生产品,结构与 THC 相似。Cesamet 用于治疗接受化疗的患者的恶心。当其他药物无法控制恶心和呕吐时,通常会开出 Cesamet。FDA 还批准 Marinol 和 Syndros 在美国用于治疗用途。Marinol 和 Syndros 含有活性成分屈大麻酚 - 一种合成的 9-THC,被认为是大麻的精神活性成分。Marinol 和 Syndros 药物用于刺激患有消瘦综合征(艾滋病的症状之一)患者的食欲。同样,各种基于大麻的产品已获批准或正在进行临床试验。例如,nabiximols (Sativex) 是加拿大批准上市的药物。Nabiximols 是一种大麻提取物,用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合而成。2020 年 2 月,加拿大公司 CanaQuest Medical Corp 向加拿大卫生部申请批准生产和商业化 Mentabinol。Mentabinol 是一种基于 THC 的产品,其批准申请已根据《大麻法》提交。FDA 对上述大麻产品的批准增加正在推动医用大麻市场的增长。

分段分析基于产品的洞察

根据产品,医用大麻市场分为干大麻和提取物两种形式。提取物部分在 2021 年占据最大份额,预计在预测期内将在医用大麻市场中实现最高复合年增长率。提取物形式部分的增长归因于多种因素,包括医疗应用对液体提取物的需求不断增加、人们对提取物优于干大麻的好处的认识不断提高,以及随着天然保健产品的消费,健康和保健趋势日益增长。

大麻提取物是一种特殊类型的大麻浓缩物。该提取物来自经过加工的大麻植物,通过去除多余的植物材料和其他杂质,保留了植物最需要和最理想的化合物。与天然大麻花相比,大麻浓缩物中萜烯和大麻素的比例更高。此外,大麻浓缩物还有助于提高大麻花的药效。出于多种原因,人们可以单独食用大麻浓缩物,而无需进一步加工。生产大麻浓缩物的一些工艺包括干法加工、干冰加工、水基加工、压力/热加工以及使用易燃或不易燃溶剂。浓缩物生产出来后,可能看起来像液体蜡、软固体或硬固体。

 

基于应用的洞察

根据应用,医用大麻市场细分为疼痛管理、图雷特氏症、阿尔茨海默病、偏头痛、抑郁和焦虑、多发性硬化症、癌症等。疼痛管理领域在 2021 年占据了医用大麻市场的最大份额,预计在预测期内将实现最高的复合年增长率。

 

基于分销渠道的洞察

就分销渠道而言,医用大麻市场分为零售药店、电子商务和其他。零售药店部门在 2021 年占据了医用大麻市场的最大份额。然而,电子商务部门预计在预测期内将实现最高的复合年增长率。

 

区域分析

2021 年,北美占据了医用大麻市场的最大市场份额,预计在预测期内将保持其市场地位。推动北美市场增长的因素包括大麻在医疗领域的应用日益广泛、与大麻益处相关的研究活动以及发达的医疗保健基础设施,这些因素可能会在预测期内为市场参与者提供更广泛的增长机会。此外,产品发布也推动了北美医用大麻市场的增长。在北美,美国占据了最大的医用大麻市场份额。老年人口不断增长,慢性病发病率不断上升,以及主要市场参与者的存在感不断扩大,推动了该国医用大麻市场的发展。此外,美国大麻合法化程度不断提高,政府对加强医用大麻研究的支持不断增加,也为 2028 年医用大麻市场的参与者提供了一个有吸引力的环境。

 

Aphria, Inc.、Canopy Growth Corporation、CanaQuest Medical Corporation、GW Pharmaceuticals、Organigram Holdings Inc.、VIVO Cannabis Inc.、Panaxia Pharmaceutical Industries Ltd.、Phoena Holdings Inc.、Emerald Health Therapeutics Inc. 和 MARICANN INC 是全球医用大麻市场增长的主要参与者。还分析了其他几家重要的市场参与者,以全面了解市场及其生态系统。该报告提供了详细的市场洞察,帮助主要参与者制定市场增长战略。以下提到了一些发展:

 

医用大麻市场报告范围

报告属性细节
2021 年市场规模117.1亿美元
2028 年市场规模400.3亿美元
全球复合年增长率(2021 - 2028)19.2%
历史数据2019-2020
预测期2022-2028
涵盖的领域按产品
  • 干燥形式和提取物形式
按应用
  • 疼痛管理
  • 妥瑞氏症
  • 阿尔茨海默氏病
  • 偏头痛
  • 抑郁和焦虑
  • 多发性硬化症
  • 癌症
  • 其他的
按分销渠道
  • 零售药店
  • 电子商务
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Aphria 公司
  • Canopy Growth 公司
  • 加拿奎斯特医疗公司
  • GW 制药公司
  • Organigram 控股公司
  • VIVO 大麻公司
  • 帕纳西亚制药工业有限公司
  • 凤凰控股有限公司
  • Emerald Health Therapeutics Inc.
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

2021 年 11 月,VIVO Cannabis Inc. 推出了其最新的医用大麻产品配方:Beacon Medical 品牌下的高剂量大麻二酚 (CBD) 油。整个 Beacon Medical 油产品系列均采用非转基因食品级中链甘油三酯 (MCT) 载体油配制而成,最终产品无味无味。VIVO 同时推出了儿科同情护理计划,以支持需要医用大麻治疗各种儿科疾病的护理人员和家庭。

2020 年 11 月,Panaxia Global 以色列子公司 Panaxia Labs Israel Ltd.(Panaxia Israel)完成了注册程序,并获得了欧洲最大、增长最快的大麻市场德国卫生当局的最终监管批准,可用于营销和分销一系列医用大麻优质产品。这些产品将以 Naxiva-Panaxol 品牌在德国销售。

2020 年 9 月,Emerald Health Therapeutics, Inc. 和 STENOCARE A/S 获得瑞典药品管理局的特别批准,向通过医生申请使用此类产品进行治疗的瑞典患者提供医用大麻油。根据 2019 年 11 月签署的协议,Emerald 向丹麦和瑞典等其他市场供应 STENOCARE 的医用大麻产品。目前,这两家公司正与瑞典当局合作,处理在瑞典开始进口和分销所需的信息。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment is dominating the medical marijuana market?

The global medical marijuana market based on product is dried form and extract form. The extract form segment is likely to hold the largest share of the market in 2022. Moreover, the segment is anticipated to register the highest CAGR in the market during the forecast period.

What are the driving factors for the medical marijuana market across the country?

The factors that are driving and restraining factors that will affect the medical marijuana market in the coming years. Factors such as increasing approvals of medical marijuana products and rising acceptance of medicinal use of marijuana in America. However, the illegal use of cannabis as a street drug and misconceptions regarding marijuana is likely to have a negative impact on the growth of the market in the coming years.

Who are the major players in the medical marijuana market?

The medical marijuana market majorly consists of the players such as Aphria, Inc.; Canopy Growth Corporation; CanaQuest Medical Corporation; GW Pharmaceuticals; Organigram Holdings Inc.; VIVO Cannabis Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; Emerald Health Therapeutics Inc.; and MARICANN INC.

What is the Medical Marijuana market?

Medical marijuana is a term for derivatives of the Cannabis sativa plant that are used to ease symptoms caused by certain medical conditions. Medical marijuana is also known as medical cannabis. Cannabis sativa contains many active compounds. The best known are delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary ingredient in marijuana. Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Medical Marijuana Market

  1. Aphria, Inc.
  2. Canopy Growth Corporation
  3. CanaQuest Medical Corporation
  4. GW Pharmaceuticals
  5. Organigram Holdings Inc.
  6. VIVO Cannabis Inc
  7. Panaxia Pharmaceutical Industries Ltd.
  8. Phoena Holdings Inc.
  9. Emerald Health Therapeutics Inc.
  10. MARICANN INC.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.